Sign In
Buy CLB
$11.77
+0.0800 (+0.684%)
At Close: Jun 22, 2026
Core Laboratories (CLB) Misses Q4 Earnings and Revenue Estimates
07:31pm, Wednesday, 29'th Jan 2025
Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.19 per share a year ago.
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
05:15pm, Wednesday, 29'th Jan 2025
FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEAR FOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YE
Core Laboratories to Post Q4 Earnings: Here's What to Expect
07:15am, Friday, 24'th Jan 2025
CLB is expected to report higher revenues from the year-ago period's level. However, despite this revenue growth, the company is expected to face increased operating expenses.
Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Wednesday, 22'nd Jan 2025
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Hold Strategy is Apt for Core Laboratories Stock Now
07:05am, Wednesday, 15'th Jan 2025
CLB benefits from strong international growth, high-margin projects and an efficient business model. However, stock underperformance, competition and U.S. market challenges pose risks.
Dublin, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The "Clinical Chemistry and Immunoassay Industry, Global, 2023-2028" report has been added to ResearchAndMarkets.com's offering. This analysis examines the gl
Is Now the Right Time to Buy Core Laboratories After Its 12% YTD Rise?
07:51am, Friday, 13'th Dec 2024
CLB shows strong earnings growth, solid cash flow and innovative technologies, but faces risks from geopolitical tensions, weak U.S. onshore activity and oil price volatility.
Why Is Core Laboratories (CLB) Up 11.5% Since Last Earnings Report?
12:37pm, Friday, 22'nd Nov 2024
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Is the Options Market Predicting a Spike in CORE LABS INC (CLB) Stock?
10:16am, Thursday, 07'th Nov 2024
Investors need to pay close attention to CORE LABS INC (CLB) stock based on the movements in the options market lately.
Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript
12:53pm, Thursday, 24'th Oct 2024
Core Laboratories Inc. (NYSE:CLB ) Q3 2024 Earnings Conference Call October 24, 2024 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Chris Hill - Chief Financial Off
Core Laboratories' Q3 Earnings and Sales Beat Estimates
07:41am, Thursday, 24'th Oct 2024
CLB expects Reservoir Description revenues of $87.5-$90.5 million and Production Enhancement revenues of $41-$45 million for the fourth quarter of 2024.
Core Laboratories (CLB) Q3 Earnings Match Estimates
07:25pm, Wednesday, 23'rd Oct 2024
Core Laboratories (CLB) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago.
CORE LAB REPORTS THIRD QUARTER 2024 RESULTS
05:15pm, Wednesday, 23'rd Oct 2024
THIRD QUARTER REVENUE OF $134.4 MILLION, UP 3% SEQUENTIALLY AND OVER 7% YEAR-OVER-YEAR THIRD QUARTER OPERATING INCOME OF $19.8 MILLION; EX-ITEMS, $18.2 MILLION, UP 11% SEQUENTIALLY AND 14% YEAR-OVER-Y
Energy Stocks to Watch Amid Q3 Earnings Despite Pricing Pressures
12:00pm, Tuesday, 22'nd Oct 2024
Energy stocks such as PUMP, CLB and OII are poised to deliver a Q3 earnings beat.
What's in Store for Core Laboratories Stock in Q3 Earnings?
08:55am, Thursday, 17'th Oct 2024
CLB is expected to report higher revenues compared with the previous quarter, along with reduced costs for services and product sales and general administrative expenses.
